Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

5.960 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,503
Open 5.960
Bid (Size) 5.900 (100)
Ask (Size) 6.100 (200)
Prev. Close 5.960
Today's Range 5.960 - 5.960
52wk Range 3.310 - 6.180
Shares Outstanding 136,360,208
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
Industry’s First End-to-End Flow Cytometry Platform Covering Panel Design Through Data Analysis 
From Cytek Biosciences, Inc.
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill

Performance

YTD
+21.1%
+21.1%
1 Month
+24.7%
+24.7%
3 Month
+30.1%
+30.1%
6 Month
+33.0%
+33.0%
1 Year
+71.8%
+71.8%

More News

Read More
News headline image
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
From Cytek Biosciences, Inc.; Sysmex Europe SE
Via GlobeNewswire
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
Via Benzinga
News headline image
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock ↗
Via Benzinga
News headline image
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Cytek Biosciences Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
From USA News Group
Via GlobeNewswire
News headline image
Cytek (CTKB) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
From Cytek Biosciences, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Cytek Biosciences, Inc. - Common Stock publicly traded?
Yes, Cytek Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Cytek Biosciences, Inc. - Common Stock trade on?
Cytek Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytek Biosciences, Inc. - Common Stock?
The ticker symbol for Cytek Biosciences, Inc. - Common Stock is CTKB on the Nasdaq Stock Market
What is the current price of Cytek Biosciences, Inc. - Common Stock?
The current price of Cytek Biosciences, Inc. - Common Stock is 5.960
When was Cytek Biosciences, Inc. - Common Stock last traded?
The last trade of Cytek Biosciences, Inc. - Common Stock was at 09/30/26 04:00 PM ET
What is the market capitalization of Cytek Biosciences, Inc. - Common Stock?
The market capitalization of Cytek Biosciences, Inc. - Common Stock is 812.71M
How many shares of Cytek Biosciences, Inc. - Common Stock are outstanding?
Cytek Biosciences, Inc. - Common Stock has 813M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.